Welcome to our year-end edition of M&A Insights, where we preview some of the themes we expect to shape deal-making over the next 12 months.
Continued volatility in the debt markets has resulted in another subdued year for...more
12/13/2023
/ Acquisitions ,
Artificial Intelligence ,
Asset Management ,
Capital Markets ,
EU ,
Financial Sponsors ,
Global Dealmaking ,
Global Market ,
Investment ,
Investors ,
Life Sciences ,
Mergers ,
Pharmaceutical Industry ,
Private Equity ,
Publicly-Traded Companies ,
Software Developers ,
Technology
Pharma companies have long collaborated with other organisations to bring new drugs to market. But what happens when their partner is an artificial intelligence (AI) company rather than another pharma business? Here, we...more
Transactions in the U.S. healthcare space rebounded in autumn, although with a greater proportion of smaller deals than in recent years. ...more
Today the 27 member states of the European Union have decided on Amsterdam as the new home of the European Medicines Agency. The decision came after three rounds of voting, with Amsterdam eventually emerging the winner after...more
Allen & Overy was delighted to be involved in the recent London Technology Week event called “Health Tech Innovators”.
?Organised by Tech London Advocates, MedCity and DigitalHealth.London, the event brought together...more